Dr. Alok Gupta

Director - Medical Oncology Medical and Haemato Oncology , Cancer Institute


See OPD timings


Trained in oncology and cancer management at the prestigious Tata Memorial Hospital, Mumbai

Former Assistant Professor of Medical Oncology at All India Institute of Medical Sciences (AIIMS), New Delhi

Former Consultant Medical Oncologist at Max Super Specialty Hospital, New Delhi

Dr. Alok Gupta is a Director of Medical and Haemato Oncology at Medanta Lucknow. He practices both solid tumour oncology and hematolymphoid oncology. His area of expertise is diagnosis and medical management of cancer, including the use of chemotherapy, targeted therapy, immunotherapy and hormonal therapy. During the last 16 years, he has worked on several oncology research projects. He has been actively involved in training, education and as a thesis guide of medical oncology residents and clinical research students.

Medical Qualifications

D.M. (Medical Oncology)Tata Memorial Hospital, Mumbai2011
M.D. (Internal Medicine)King George Medical University, Lucknow2008
M.B.B.S.Kasturba Medical College, Manipal University2002

Specialization and Expertise

  • Chemotherapy for Cancer Management
  • Immunotherapy
  • Management of Solid Organ Cancers
  • Management of Hematological Cancers

Memberships & Certifications

  • American Society of Clinical Oncology (ASCO)
  • European Society of Medical Oncology (ESMO)
  • Delhi Oncology Forum
  • Indian Society of Oncology (ISO)
  • Delhi Urological Society (DUS)
  • Forum of Obstetricians and Gynecologists South Delhi (FOGSD)
  • Delhi Tumour Board
  • Indian Society of Medical and Paediatric Oncology (ISMPO)

Awards & Accomplishments

  • First prize in Gynae-oncology Tumor Board Competition at 25th Annual Conference of Association of Gynaecologic Oncologists of India, 2017
  • First prize in quiz on Acute Leukemia at Annual Conference of Mumbai Hematology Group, 2014
  • First prize in quiz on Multiple Myeloma at Mumbai Hematology Group, 2014
  • Third prize in quiz on Bone Marrow Transplantation at National Cancer Congress, 2014
  • First prize in presentation entitiled, “Hepatitis B Related Serological Events in Hematopoietic Stem Cell Transplant Patients and Efficacy of Lamivudine Prophylaxis Against Reactivation,” at National Cancer Congress 2014, 2014


  • Journal of cancer research and therapeutics :   Lomustine, cytarabine, cyclophosphamide, etoposide - An effective conditioning regimen in autologous hematopoietic stem cell transplant for primary refractory or relapsed lymphoma: Analysis of toxicity, long-term outcome, and prognostic factors., 2018
    Click here for Publications Link
  • Journal of cancer research and therapeutics :   Analysis of factors affecting initial cyclosporine level and its impact on post transplant outcomes in acute leukemia., 2017
    Click here for Publications Link
  • Indian Journal of Hematology and Blood Transfusion :   Cyclosporine Plus Methotrexate or Cyclosporine Plus Mycophenolate Mofetil as Graft Versus Host Disease Prophylaxis in Acute Leukemia Transplant: Comparison of Toxicity, Engraftment Kinetics and Transplant Outcome, 2016
    Click here for Publications Link
  • Hematological Oncology  :   Hepatitis B-related serological events in hematopoietic stem cell transplant patients and efficacy of lamivudine prophylaxis against reactivation., 2016
    Click here for Publications Link
  • Indian Journal of Hematology and Blood Transfusion :   Chronic Graft Versus Host Disease in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant: Analysis of Risk Factors, Pattern and Long Term Outcome, 2016
    Click here for Publications Link
  • International Journal of Hematology :   Comparison of LACE with BCNU-Containing Conditioning Regimens in Lymphoma Transplant: A Retrospective Multicenter Analysis., 2016
  • Indian Journal of Hematology and Blood Transfusion :   Risk factors, pattern and clinical outcome of Acute Graft versus Host Disease in Acute Leukemia patients undergoing Allogeneic Stem Cell Transplant - Analysis from a tertiary cancer centre., 2015
    Click here for Publications Link
  • Indian J Med Paediatr Oncol :   Down-staging following neoadjuvant chemo-radiotherapy for locally advanced rectal cancer: Does timing of surgery really matter?, 2014
    Click here for Publications Link